Response Genetics, Inc (RGDXQ)
OTCMKTS · Delayed Price · Currency is USD
0.000001
-0.000001 (-50.00%)
At close: Aug 12, 2026
Response Genetics Market Cap
Response Genetics has a market cap or net worth of $39 as of October 14, 2026. It is the 53,070th most valuable company in the world and the 9,090th biggest in the United States.
Market Cap
39.00
Enterprise Value
n/a
Revenue
16.62M
Global Rank
Country Rank
#9,090 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 6, 2007, Response Genetics's market cap has decreased from 71.67M to 39.00, a decrease of -100.00%. That is a compound annual growth rate of -52.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 39.00 | - |
| Dec 24, 2025 | 39.00 | -99.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RushNet | 8.77K |
| Todos Medical | 3.32K |
| Medivolve | 2.70K |
| Arrayit | 1.13K |
| Rosetta Genomics | 593.00 |
| Biomagnetics Diagnostics | 278.00 |
| Biocept | 263.00 |
| Cyclo3pss | 41.00 |